ARTICLE | Company News
Japan Tobacco, Torii, Toray deal
January 2, 2012 8:00 AM UTC
The companies mutually terminated their 2006 deal to develop and commercialize Toray's TRK-820 in Japan to treat pruritus in chronic liver disease patients. The kappa opioid receptor agonist is in P...